These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3691762)

  • 1. Urinary hydroxyproline excretion in the myelofibrosis-osteomyelosclerosis syndrome and related diseases.
    Hasselbalch H
    Eur J Haematol; 1987 Nov; 39(5):447-51. PubMed ID: 3691762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary hydroxyproline excretion in myelofibrosis.
    Wang JC; Aung MK; Tobin MS
    Blood; 1980 Mar; 55(3):383-5. PubMed ID: 7357076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyprolinuria and hypercalcaemia during immobilization in patients with idiopathic myelofibrosis.
    Baglin TP; Boughton BJ
    Clin Lab Haematol; 1988; 10(1):25-8. PubMed ID: 3365931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
    Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
    Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study.
    Lisse I; Hasselbalch H; Junker P
    APMIS; 1991 Feb; 99(2):171-8. PubMed ID: 2001283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD; Risteli L; Risteli J
    Am J Hematol; 1986 Oct; 23(2):101-11. PubMed ID: 3752065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and histological analysis of bone marrow collagen in myelofibrosis.
    Charron D; Robert L; Couty MC; Binet JL
    Br J Haematol; 1979 Feb; 41(2):151-61. PubMed ID: 427028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation.
    Dalley A; Smith JM; Reilly JT; Neil SM
    Br J Haematol; 1996 Jun; 93(4):856-62. PubMed ID: 8703817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DIAGNOSIS OF MYELOFIBROSIS AND OSTEOMYELOSCLEROSIS].
    PAPAGEORGIOU A
    Dtsch Med Wochenschr; 1965 Mar; 90():436-7. PubMed ID: 14242203
    [No Abstract]   [Full Text] [Related]  

  • 10. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
    Hasselbalch H; Lisse I
    Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
    Nagao T; Yonekura S
    Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary excretion of hydroxyproline in parathyroid disorders, with special reference to its changes before and after parathyroidectomy in primary hyperparathyroidism].
    Yumita S
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):949-61. PubMed ID: 6685063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
    Kelleher PC
    Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of collagen metabolism in myelofibrosis.
    Fruchtman SM
    Prog Clin Biol Res; 1984; 154():467-74. PubMed ID: 6382307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of myelofibrosis-derived fibroblasts.
    Castro-Malaspina H; Jhanwar SC
    Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary hydroxyproline excretion in acromegaly.
    Halse J; Gordeladze JO
    Acta Endocrinol (Copenh); 1978 Nov; 89(3):483-91. PubMed ID: 707006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Findings on total hydroxyproline excretion in patients with scoliosis].
    Agostini S; Scalella P; Fabris D
    Clin Ortop; 1974; 25(4):205-8. PubMed ID: 4471240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary myelofibrosis with progressive generalized osseous eburnation.
    BERSACK SR; FEINSTEIN HR
    Am J Roentgenol Radium Ther; 1946 Oct; 56():470-9. PubMed ID: 21000819
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum procollagen III peptide in chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD
    Scand J Haematol; 1985 Nov; 35(5):550-7. PubMed ID: 4089533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature.
    Singh DK; Mahajan D; Nigam S; Singh T
    Hematology; 2008 Apr; 13(2):83-7. PubMed ID: 18616873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.